This compound is a structurally complex aromatic ether derivative featuring multiple alcohol and amine functional groups, characterized by high flexibility and two aromatic rings. It is identified as an active pharmaceutical ingredient impurity, primarily relevant in quality control and pharmaceutical manufacturing processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
CAP18
pharmaceutical raw material
Retinyl retinoate
pharmaceutical raw material
Methylscopolamine bromide
pharmaceutical raw material
Pyridostigmine
pharmaceutical raw material
Atenolol impurity D
pharmaceutical raw material
Acebutolol dimer
pharmaceutical intermediate
1-[[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl]-propan-2-ylamino]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
FPFJXNCXQDHWGC-UHFFFAOYSA-N
CC(C)N(CC(COC1=CC=C(C=C1)CCOC)O)CC(COC2=CC=C(C=C2)CCOC)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.